The acute pulmonary inflammatory response to the graded severity of smoke inhalation injury

Critical Care Medicine

Volumn 40, Issue 4, 2012, Pages 1113-1121

  Albright, Joslyn M ^a   Davis, Christopher S ^a   Bird, Melanie D ^a   Ramirez, Luis ^a   Kim, Hajwa ^b   Burnham, Ellen L ^c   Gamelli, Richard L ^a   Kovacs, Elizabeth J ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

burn; chemokin; cytokine; growth factor; inflammation; inhalation injury

Indexed keywords

CARBOXYHEMOGLOBIN; COMPLEMENT COMPONENT C5A; EOTAXIN; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTIFICIAL VENTILATION; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INJURY SEVERITY; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE COUNT; LUNG BURN; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHILIA; OBSERVATIONAL STUDY; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; SEPSIS; TRACHEOSTOMY; TREATMENT DURATION;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; CYTOKINES; FEMALE; HUMANS; INJURY SEVERITY SCORE; MALE; MIDDLE AGED; PNEUMONIA; SEVERITY OF ILLNESS INDEX; SMOKE INHALATION INJURY; TREATMENT OUTCOME;

EID: 84858776579     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182374a67     Document Type: Review

References (47)

1. Burn Incidence Fact Sheet (2007). American Burn Association. Available at: http://ameriburn. org. Accessed August 22, 2010
2. Latenser BA, Miller SF, Bessey PQ, et al: National Burn Repository 2006 Report Dataset Version 3. 0. J Burn Care Res 2007 Jul 24 [Epub ahead of print]
3. Saffle JR, Davis B, Williams P: Recent outcomes in the treatment of burn injury in the United States: A report from the American Burn Association Patient Registry. J Burn Care Rehabil 1995; 16(3 Pt 1):219-232, discussion 288-289
4. Navar PD, Saffle JR, Warden GD: Effect of inhalation injury on fluid resuscitation requirements after thermal injury. Am J Surg 1985; 150(6):716-720
5. Dai NT, Chen TM, Cheng TY, et al: The comparison of early fluid therapy in extensive flame burns between inhalation and noninhalation injuries. Burns 1998; 24:671-675
6. Cancio LC, Chávez S, Alvarado-Ortega M, et al: Predicting increased fluid requirements during the resuscitation of thermally injured patients. J Trauma 2004; 56:404-413; discussion 413-414
7. Edelman DA, White MT, Tyburski JG, et al: Factors affecting prognosis of inhalation injury. J Burn Care Res 2006; 27:848-853
8. Edelman DA, Khan N, Kempf K, et al. Pneumonia after inhalation injury. J Burn Care Res 2007; 28:241-246
9. Kurzius-Spencer M, Foster K, Littau S, et al: Tracheobronchial markers of lung injury in smoke inhalation victims. J Burn Care Res 2008; 29:311-318
10. Wright MJ, Murphy JT: Smoke inhalation enhances early alveolar leukocyte responsiveness to endotoxin. J Trauma 2005; 59:64-70
11. Endorf FW, Gamelli RL: Inhalation injury, pulmonary perturbations, and fluid resuscitation. J Burn Care Res 2007; 28:80-83
12. Wahl WL, Ahrns KS, Brandt MM, et al: Bronchoalveolar lavage in diagnosis of ventilator-associated pneumonia in patients with burns. J Burn Care Rehabil 2005; 26:57-61
13. Clark WR Jr: Smoke inhalation: Diagnosis and treatment. World J Surg 1992; 16:24-29
14. Enkhbaatar P, Traber DL: Pathophysiology of acute lung injury in combined burn and smoke inhalation injury. Clin Sci (Lond) 2004; 107:137-143
15. Soejima K, Schmalstieg FC, Sakurai H, et al: Pathophysiological analysis of combined burn and smoke inhalation injuries in sheep. Am J Physiol Lung Cell Mol Physiol 2001; 280:L1233-L1241
16. Lange M, Hamahata A, Traber DL, et al: A murine model of sepsis following smoke inhalation injury. Biochem Biophys Res Commun 2010; 391:1555-1560
17. Mizutani A, Enkhbaatar P, Esechie A, et al: Pulmonary changes in a mouse model of combined burn and smoke inhalation-induced injury. J Appl Physiol 2008; 105:678-684
18. Westphal M, Cox RA, Traber LD, et al: Combined burn and smoke inhalation injury impairs ovine hypoxic pulmonary vasoconstriction. Crit Care Med 2006; 34:1428-1436
19. Westphal M, Morita N, Enkhbaatar P, et al: Acute effects of combined burn and smoke inhalation injury on carboxyhemoglobin formation, tissue oxygenation, and cardiac performance. Biochem Biophys Res Commun 2004; 317:945-949
20. Lange M, Cox RA, Enkhbaatar P, et al: Predictive role of arterial carboxyhemoglobin concentrations in ovine burn and smoke inhalation-induced lung injury. Exp Lung Res 2011; 37:239-245
21. Mitchell LA, Channell MM, Royer CM, et al: Evaluation of inhaled carbon monoxide as an anti-inflammatory therapy in a nonhuman primate model of lung inflammation. Am J Physiol Lung Cell Mol Physiol 2010; 299:L891-L897
22. Kanagawa F, Takahashi T, Inoue K, et al: Protective effect of carbon monoxide inhalation on lung injury after hemorrhagic shock/resuscitation in rats. J Trauma 2010; 69:185-194
23. Goebel U, Siepe M, Mecklenburg A, et al: Reduced pulmonary inflammatory response during cardiopulmonary bypass: Effects of combined pulmonary perfusion and carbon monoxide inhalation. Eur J Cardiothorac Surg 2008; 34:1165-1172
24. Zhou H, Qian H, Liu J, et al: Protection against lung graft injury from brain-dead donors with carbon monoxide, biliverdin, or both. J Heart Lung Transplant 2011; 30:460-466
25. Riyami BM, Tree R, Kinsella J, et al: Changes in alveolar macrophage, monocyte, and neutrophil cell profiles after smoke inhalation injury. J Clin Pathol 1990; 43:43-45
26. Ettensohn DB, Jankowski MJ, Duncan PG, et al: Bronchoalveolar lavage in the normal volunteer subject. I. Technical aspects and intersubject variability. Chest 1988; 94:275-280
27. Rodriguez JL, Miller CG, Garner WL, et al: Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J Trauma 1993; 34:684-695
28. Murakami K, Traber DL: Pathophysiological basis of smoke inhalation injury. News Physiolog Sci 2003; 18:125-129
29. Traber DL, Linares HA, Herndon DN, et al: The pathophysiology of inhalation injury-A review. Burns Incl Therm Inj 1988; 14:357-364
30. Shirani KZ, Pruitt BA Jr, Mason AD Jr: The influence of inhalation injury and pneumonia on burn mortality. Ann Surg 1987; 205:82-87
31. Davis CS, Albright JM, Carter SR, et al: Early pulmonary immune hyporesponsiveness is associated with mortality after burn and smoke inhalation injury. J Burn Care Res 2012; 33:26-35
32. Dinarello CA: The interleukin-1 family: 10 years of discovery. FASEB J 1994; 8:1314-1325
33. Chen LW, Chang WJ, Wang JS, et al: Interleukin-1 mediates thermal injury-induced lung damage through C-Jun NH2-terminal kinase signaling. Crit Care Med 2007; 35:1113-1122
34. Fleischmann RM, Tesser J, Schiff MH, et al: Safety of extended treatment with anakinra in patients with rheumatoid arthritis. Ann Rheum Dis 2006; 65:1006-1012
35. Endo S, Inada K, Yamada Y, et al: Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns. J Med 1996; 27(1-2):57-71
36. Vindenes HA, Ulvestad E, Bjerknes R: Concentrations of cytokines in plasma of patients with large burns: Their relation to time after injury, burn size, inflammatory variables, infection, and outcome. Eur J Surg 1998; 164:647-656
37. Steensberg A, Fischer CP, Keller C, et al: IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 2003; 285:E433-E437
38. Mizel SB: The interleukins. FASEB J 1989; 3:2379-1388
39. Molloy RG, Mannick JA, Rodrick ML: Cytokines, sepsis and immunomodulation. Br J Surg 1993; 80:289-297
40. Kaplanski G, Farnarier C, Kaplanski S, et al: Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 1994; 84:4242-4248
41. Polk HC Jr, Cheadle WG, Livingston DH, et al: A randomized prospective clinical trial to determine the efficacy of interferon-gamma in severely injured patients. Am J Surg 1992; 63:191-196
42. Dries DJ, Jurkovich GJ, Maier RV, et al: Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial. Arch Surg 1994; 129:1031-1042
43. Mooney DP, Gamelli RL: Sepsis following thermal injury. Compr Ther 1989; 15:22-29
44. Hershman MJ, Appel SH, Wellhausen SR, et al: Interferon-gamma treatment increases HLA-DR expression on monocytes in severely injured patients. Clin Exp Immunol 1989; 77:67-70
45. Suzuki F, Pollard RB: Alterations of interferon production in a mouse model of thermal injury. J Immunol 1982; 129:1806-1810
46. Wasserman D, Ioannovich JD, Hinzmann RD, et al: Interferon-gamma in the prevention of severe burn-related infections: A European phase III multicenter trial. The Severe Burns Study Group. Crit Care Med 1998; 26:434-439
47. Nakos G, Malamou-Mitsi VD, Lachana A, et al: Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma. Crit Care Med 2002; 30:1488-1494